ASK PHARM(SZ:002755) Xin Lang Cai Jing·2025-08-26 05:57Company Overview - Aosaikang Pharmaceutical Co., Ltd. is located in Jiangning Science Park, Nanjing, Jiangsu Province, and was established on December 24, 1996. The company was listed on May 15, 2015. Its main business involves the research, production, and sales of drugs, particularly in the fields of digestive, anti-tumor, and other medications [1][2]. Financial Performance - For the first quarter of 2025 (January to March), Aosaikang achieved a revenue of 509 million yuan, representing a year-on-year growth of 13.39%. The net profit attributable to shareholders was 54.73 million yuan, showing a significant increase of 73.50% compared to the previous year [2]. - Since its A-share listing, Aosaikang has distributed a total of 721 million yuan in dividends, with 111 million yuan distributed over the past three years [3]. Stock Performance - As of August 26, Aosaikang's stock price was 25.01 yuan per share, with a market capitalization of 23.213 billion yuan. The stock has increased by 98.65% year-to-date, but has seen a decline of 1.96% over the past five trading days and a 10.36% drop over the past 20 days [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on July 16 [1]. Shareholder Information - As of August 20, Aosaikang had 18,300 shareholders, a decrease of 1.26% from the previous period. The average number of circulating shares per shareholder increased by 1.28% to 50,724 shares [2]. - Among the top ten circulating shareholders as of March 31, 2025, notable new entrants include China Europe Medical Health Mixed A and E Fund Medical Health Industry Mixed A, while Hong Kong Central Clearing Limited has exited the list [3]. Industry Classification - Aosaikang is classified under the pharmaceutical and biological industry, specifically in the chemical pharmaceutical sector, with a focus on innovative drugs, pharmaceutical e-commerce, and cancer treatment [2].